As healthcare professionals, we are witnessing an alarming increase in obesity rates worldwide. This rise is accompanied by a surge in associated comorbidities like type 2 diabetes, cardiovascular diseases, and certain types of cancer. Hence, it is crucial to explore effective strategies for managing obesity.
Behavioral interventions form the cornerstone of obesity management. They involve dietary modifications, physical activity enhancement, and behavioral changes. These interventions can be delivered individually or in groups, face-to-face or remotely. The key is to customize the approach based on patient's needs and preferences.
Pharmacotherapy can be considered in patients with a BMI ≥30 or ≥27 with comorbidities, who have not responded to behavioral interventions. The choice of drug should be guided by the patient's comorbid conditions, potential side effects, and cost. Regular follow-up is essential to monitor efficacy and adverse effects.
Endoscopic and surgical interventions are reserved for patients with severe obesity (BMI ≥40 or ≥35 with comorbidities) who have not responded to non-surgical strategies. While these methods have shown significant weight loss and improvement in comorbid conditions, they are associated with potential complications and require lifelong medical follow-up.
Managing obesity requires an interdisciplinary approach involving dietitians, exercise physiologists, behavioral therapists, pharmacists, and surgeons. This team-based approach ensures comprehensive care, addressing all aspects of obesity.
Obesity management is a complex, multifaceted process requiring a personalized, patient-centered approach. It involves behavioral interventions, pharmacotherapy, endoscopic or surgical interventions, and an interdisciplinary team approach. As healthcare professionals, we need to stay updated with the latest evidence-based strategies to provide optimal care to our patients with obesity.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation